ATXI

Avenue Therapeutics Inc
1.34
-0.04 (-2.90%)

Avenue Therapeutics Inc. (ATXI) Fundamentals

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.
SHARE INFORMATION
Market Cap$ 6,595,395
Shares Outstanding4,779,272
Float4,741,427
Percent Float99.21%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.34
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions41
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months13,632
Institutional Holdings Percent2.2%
Institutional Sold Previous 3 Months385,076
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent33.4
Insider Sold Previous 3 Months388,888
Insider Shares Owned1,595,805
TRADING INFO
52 Week High$ 18.75
52 Week Low$ 1.06
52 Week High Change$ -86.67
21 Day Moving Average$ 1.3514
21 Day Extended Moving Average$ 1.4294
50 Day Moving Average$ 1.3836
50 Day Extended Moving Average$ 1.6593
200 Day Moving Average$ 3.6086
200 Day Extended Moving Average$ 5.8039
10 Day Average Volume3,824,313
20 Day Average Volume1,999,137
30 Day Average Volume1,436,883
50 Day Average Volume987,070
Alpha0.000166
Beta-0.5948
Standard Deviation0.355697
R20.008131
7 Day Price Change$ -0.12
7 Day Percent Change-8.0%
21 Day Price Change$ 0.22
21 Day Percent Change18.97%
30 Day Price Change$ 0.16
30 Day Percent Change13.11%
Month to Date Price Change$ 0.22
Month to Date Percent Change18.97%
Quarter to Date Price Change$ 0.22
Quarter to Date Percent Change18.97%
180 Day Price Change$ -2.66
180 Day Percent Change-65.8%
200 Day Price Change$ -2.89
200 Day Percent Change-67.7%
Year to Date Price Change$ 0.22
Year to Date Percent Change18.97%

Avenue Therapeutics Inc. (ATXI) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-169.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.90
Leverage Ratio2.10
Quick Ratio0.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ 6,378,395
Price to Sales0.00
Price to Free Cash-1.90
PE High Last 5 Years-3.30
Price To Book14.30
Price To Cash Flow0.00
PE Low Last 5 Years-9.50
Price to Tangible Book-169.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-870.59
Return on Equity5,775.10
Return on Capital-847.42

Avenue Therapeutics Inc. (ATXI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOAlexandra MacLean
Emplyoees4
Last AuditUE
CIK0001644963
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1140 Avenue of the Americas
9th Floor
New York, NY 10036
Websitehttps://www.avenuetx.com
Facsimile-
Telephone+1 781 652-4500
Emailjeremy@lifesciadvisors.com


Your Recent History
NASDAQ
ATXI
Avenue The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.